Outcomes of Pulmonary Valve Replacement With the INSPIRIS (Model 11500A) Valve

Heart Valve Prosthesis Clinical Trial

Official title:
Outcomes of Pulmonary Valve Replacement With the INSPIRIS (Model 11500A) Valve for Pulmonary Valve Replacement in Children and Young Adults

Status Recruiting

Clinical Trial Summary

The goal of this retrospective chart review is to contribute to the literature on the mid-term durability and hemodynamics of the INSPIRS Resilia bioprosthesis when implanted in children and young adults.

Clinical Trial Description

The primary objective of our study is to contribute to the scarce body of literature on the mid-term durability and hemodynamics of the INSPIRIS Resilia (model 11500) bioprosthesis when implanted in the pulmonary position in children and young adults. Investigators also aim to identify: effect of age on SVD, freedom from SVD, pathology of SVD, valve-related complications, freedom from re-operation, and survival rate. ;

Study Design

Related Conditions & MeSH terms

Heart Valve Prosthesis

Clinical Trial Details

NCT number	NCT05986396
Study type	Observational
Source	Baylor College of Medicine
Contact	Rosario Ocampo, BSN
Phone	210-704-4996
Email	rosario.ocampo@christushealth.org
Status	Recruiting
Phase
Start date	January 3, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03965065` - Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement	N/A
Suspended	`NCT01042067` - Safer Warfarin Treatment	N/A
Recruiting	`NCT03797534` - Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes	N/A
Terminated	`NCT01505881` - Follow on Study From RE-ALIGN	Phase 2